Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00543296 · ClinicalTrials.gov registry record · Phase 4
Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT00543296 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 21 participants.
The verdict
NCT00543296, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data on patients with severe uveitis that have required re-implantation of the sustained-release fluocinolone drug delivery device due to depletion of study drug in their previous implanted device.
Interventions
- DRUG 0.59 mg Fluocinolone Acetonide implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2004-03 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00543296
The ClinicalTrials.gov registry entry for NCT00543296 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 0.59 mg Fluocinolone Acetonide implant is the first listed.
NCT00543296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00543296 about?
NCT00543296 is a clinical study titled "Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment". The purpose of this study is to collect data on patients with severe uveitis that have required re-implantation of the sustained-release fluocinolone drug delivery device due to depletion of study drug in their previous implanted device.
What is the current status of trial NCT00543296?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2004-03. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00543296?
The interventions under investigation include: 0.59 mg Fluocinolone Acetonide implant (DRUG).
Who is sponsoring clinical trial NCT00543296?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.